Regulated IRE1 alpha-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer - Centre Eugène Marquis Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2022

Regulated IRE1 alpha-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer

Résumé

IRE1α is constitutively active in several cancers and can contribute to cancer progression. Activated IRE1α cleaves XBP1 mRNA, a key step in production of the transcription factor XBP1s. In addition, IRE1α cleaves select mRNAs through regulated IRE1α-dependent decay (RIDD). Accumulating evidence implicates IRE1α in the regulation of lipid metabolism. However, the roles of XBP1s and RIDD in this process remain ill-defined. In this study, transcriptome and lipidome profiling of triple negative breast cancer cells subjected to pharmacological inhibition of IRE1α reveals changes in lipid metabolism genes associated with accumulation of triacylglycerols (TAGs). We identify DGAT2 mRNA, encoding the rate-limiting enzyme in TAG biosynthesis, as a RIDD target. Inhibition of IRE1α, leads to DGAT2-dependent accumulation of TAGs in lipid droplets and sensitizes cells to nutritional stress, which is rescued by treatment with the DGAT2 inhibitor PF-06424439. Our results highlight the importance of IRE1α RIDD activity in reprograming cellular lipid metabolism.

Domaines

Cancer
Fichier principal
Vignette du fichier
41467_2022_Article_30159.pdf (2.25 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03689648 , version 1 (07-06-2022)

Licence

Paternité

Identifiants

Citer

Aitor Almanza, Katarzyna Mnich, Arnaud Blomme, Claire M. Robinson, Giovanny Rodriguez-Blanco, et al.. Regulated IRE1 alpha-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer. Nature Communications, 2022, 13 (1), pp.2493. ⟨10.1038/s41467-022-30159-0⟩. ⟨hal-03689648⟩
67 Consultations
50 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More